Dexamethasone primes adipocyte precursor cells for differentiation by enhancing adipogenic competency

ZUBIRÍA, MARÍA GUILLERMINA; ALZAMENDI, ANA; SPINEDI, EDUARDO; GIORDANO, ALEJANDRA PAULA; FRONTINI-LÓPEZ, YESICA ROMINA; GIOVAMBATTISTA, ANDRÉS; GAMBARO, SABRINA ELIANA; MORENO, GRISELDA

LIFE SCIENCES

PERGAMON-ELSEVIER SCIENCE LTD

Año: 2020 vol. 261

0024-3205

Aim: Dexamethasone (DXM) is a synthetic glucocorticoid whose effects in early and terminal adipogenesis have been addressed. In this study, we evaluated if DXM affects adipocyte precursor cells (APCs), priming them for further adipogenic differentiation. For this purpose, we analyzed APCs number and competency after DXM treatment. Materials and methods: Adult male rats were injected for 2 or 7 days with either DXM (30 μg/kg of weight, sc.) or vehicle. Stromal vascular fraction (SVF) cells from retroperitoneal adipose tissue (RPAT) were isolated to quantify APCs by flow cytometry (CD34+/CD45−/CD31−). Also, expression of competency markers (PPARγ2 and Zfp423) was assessed. Additionally, SVF cells from control rats were incubated with DXM (0.25 μM) alone or combined with a mineralocorticoid receptor (MR) antagonist (Spironolactone 10 μM) and/or a glucocorticoid receptor (GR) antagonist (RU486 1 μM) to assess APCs competency and adipocyte differentiation. Key findings: APCs from 2 days DXM-treated rats showed increased expression of PPARγ2 and Zfp423 (competency markers), but did not affect APCs percentage by FACS analysis (CD34+/CD45−/CD31−). Additionally, we found that DXM treatment in SVF also increased APCs competency in vitro, predisposing APCs to further adipocyte differentiation. These effects on APCs were abrogated only when both, MR and GR, were blocked. Significance: Overall, our results suggest that DXM primes APCs for differentiation mainly by enhancing Zfp423 and PPARγ2 expressions. Also, we showed that the inhibition of MR and GR was necessary for the complete abolishment of DXM effects.